ROTHBLATT MARTINE A bought UTHR
September 12, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 4,000 shares of United Therapeutics Corporation at $120.26 per share, a transaction worth $481.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$120.26
Total value
$481.0K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 12, 2025
Filing dateSeptember 16, 2025
Shares owned after4,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. Thisplan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.